A new centre launched in northeast England to deliver innovative model of care


Share post:

LloydsPharmacy Clinical Homecare (LCPH) has launched a new centre in Westerhope, in  partnership with Newcastle upon Tyne Hospitals NHS Foundation Trust, to deliver an innovative model of care.

The new centre provides injection and infusion services patients, while supporting the NHS by increasing capacity and taking care away from a hospital setting.

Patients, in turn, get flexibility, convenience and choice to take ownership of their treatment journey.

LPCH says the service at its fourth healthcare centre operates five days a week, and delivers approximately 14 patient treatments each day, with the capacity to reach 20.

The centre runs in partnership with global pharmaceutical companies MSD and Bristol Myers Squibb, who manufacture the medication with which the patients are treated.

LPHS claims that so far it has helped NHS Trusts release 4,707 nursing hours.

Commenting on the launch of the new centre, Nick Davis, CEO of LloydsPharmacy Clinical Homecare, said the clinic represented “a fantastic alternative treatment pathway for so many patients”, particularly those that didn’t have easy access to such an option.

“Equally, it’s also about generating financially efficient solutions for the NHS, and creating much-needed capacity in NHS hospitals and clinics, so that they can also service more patients.”


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...